SAN FRANCISCO--(BUSINESS WIRE)--Trilobio, developer of whole lab automation solutions for advancing biology research, today introduced the first version of its comprehensive robotics, lab equipment ...
Autonomy, by contrast, is about decision‑making and adaptation. The leap from automation to autonomy is not just more actuators; it is a system that can perceive its environment, reason about options, ...
"Siemens Healthineers (Germany), Tecan Group (Switzerland), Thermo Fisher Scientific (US), Waters Corporation (US), Abbott Laboratories (US), Agilent Technologies (US ...
Labroots is delighted to host the 10th Annual Event in the Laboratory Automation Virtual Event Series, scheduled on March 18th, 2026! Dive into the cutting edge of laboratory technology at this free ...
Employee burnout rates in the healthcare sector were exceptionally high even before COVID-19. Burnout has a significant adverse influence on clinicians’ overall well-being, as well as their sense of ...
MENLO PARK, Calif.--(BUSINESS WIRE)--Strateos, Inc., a pioneer in the development of remote access laboratories and lab automation software for life science research, today announced the availability ...
11d
Multiply Labs to Bring 'Physical AI' Robotics Technology to Advanced Biomanufacturing With NVIDIA
By integrating NVIDIA’s digital twins, foundation models and perception AI, Multiply Labs is pioneering a new era of robotic ...
NewsMedical talks to Bruker BioSpin about how Chemspeed’s modular automation systems integrate with NMR technology to enable smarter, more autonomous labs. Chemspeed systems are known for their ...
Researchers in the the labs of Ron Alterovitz, a Lawrence Grossberg Distinguished Professor in the Department of Computer Science, and Jim Cahoon, a professor and chair of the Department of Chemistry, ...
AKRON—What makes a lab Industry 4.0? It might not be what you think. "Most people think the introduction of robots and computers is Industry 4.0," said Khaled Boqaileh, co-founder and CEO of LabsCubed ...
Conventional treatment options for patients diagnosed with solid cancers or autoimmune diseases are often limited or ineffective. Developing alternative treatments for these challenging conditions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results